The Roles of Stem Cell Memory T Cells in Hematological Malignancies.

Ling Xu,Yikai Zhang,Gengxin Luo,Yangqiu Li
DOI: https://doi.org/10.1186/s13045-015-0214-5
IF: 28.5
2015-01-01
Journal of Hematology & Oncology
Abstract:Adoptive cell therapy (ACT) is rapidly migrating from bench to clinical therapy for hematological malignancies. Recently, a new subtype of memory T cells, stem cell memory T (TSCM) cells, was shown to be one of the most favorable subsets for ACT. TSCM has high self-renewal capacity and is associated with superior T cell engraftment, persistence, and antitumor immunity. In this review, we focused on the characteristics of antigen-specific TSCM cells and discussed their potential for immunotherapy targeting hematological malignancies.
What problem does this paper attempt to address?